Press release, Helsinki, 10 December 2020 at 12.30 pm (EET) Nexstim Has Received Two New NBT® System Purchase Orders in the United States Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") ...
Press Release, Helsinki, 4 February 2020 at 11.15 am (EET) Nexstim NBT® System with SmartFocus® TMS installed at Mind Matters PsychiatryMD, US Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company ...
brain stimulation The FDA has cleared a non-invasive brain stimulation system for treating depression. The Food and Drug Administration (FDA) has cleared Nexstim’s ‘NBT’ system, a non-invasive brain ...
The Food and Drug Administration (FDA) has cleared a 3-minute session protocol, Theta Burst Stimulation, for the NBT System (Nexstim) used to treat major depressive disorder (MDD). Previously, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results